Virtual Medicinal Product (VMP) - Spironolactone 13.5mg/5ml oral solution
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Spironolactone 13.5mg/5ml oral solution | Start Date 21-02-2008 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral solution
- Ontology Form/Route
- solution.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- C03DA01
- BNF Codes
-
- BNF code 02020300
| Code | Start Date | End Date |
|---|---|---|
| 13325811000001103 | 21-02-2008 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Spironolactone | Based on Ingredient Substance | 2.7 mg | 1 ml |
Name
Spironolactone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2.7
Strength and UOM (Dmr)
1
Parent Products
-
VTMSpironolactone
-
VMP(Current) Spironolactone 13.5mg/5ml oral solution
-
AMP
No AMPs
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |